Coegin Pharma AB (NGM:COEGIN)

Market Cap	151.26M
Revenue (ttm)	n/a
Net Income (ttm)	-22.29M
Shares Out	24.88M
EPS (ttm)	-0.95
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	39,394
Average Volume	40,865
Open	n/a
Previous Close	6.18
Day's Range	n/a
52-Week Range	2.89 - 9.52
Beta	1.27
RSI	42.60
Earnings Date	Nov 20, 2025

About Coegin Pharma AB

Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate whic...

• Industry: Pharmaceutical Preparations
• Founded: 2005
• Employees: 1
• Stock Exchange: Nordic Growth Market
• Ticker Symbol: COEGIN